trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
López-Solache I et al. Regulation of uncoupling protein-2 mRNA in L6 myotubules: II: Thyroid hormone amplifies stimulation of uncoupling protein-2 gene by thiazolidinediones and other peroxisome proliferator-activated receptor ligands in L6 myotubules: evidence for a priming effect. 2002 Endocrine pmid:12588052
Stimson KM and Vertino PM Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. 2002 J. Biol. Chem. pmid:11733524
Kim JY et al. Probing lysine acetylation with a modification-specific marker ion using high-performance liquid chromatography/electrospray-mass spectrometry with collision-induced dissociation. 2002 Anal. Chem. pmid:12433071
Elaut G et al. Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomes. 2002 Drug Metab. Dispos. pmid:12433798
Yáñez RJ and Porter AC A chromosomal position effect on gene targeting in human cells. 2002 Nucleic Acids Res. pmid:12433992
Takechi S et al. Chicken HDAC2 down-regulates IgM light chain gene promoter activity. 2002 Biochem. Biophys. Res. Commun. pmid:12437980
Ego T et al. The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. 2002 Oncogene pmid:12370815
Zhang W and Kone BC NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases. 2002 Am. J. Physiol. Renal Physiol. pmid:12372765
Ailenberg M and Silverman M Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression. 2002 Biochem. Biophys. Res. Commun. pmid:12379227
Herold C et al. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. 2002 J. Hepatol. pmid:11830335
Yamashita K et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. 2002 Cancer Cell pmid:12498717
Zhou DC et al. Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. 2002 Blood pmid:11830487
Fahrner JA et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. 2002 Cancer Res. pmid:12499261
Valapour M et al. Histone deacetylation inhibits IL4 gene expression in T cells. 2002 J. Allergy Clin. Immunol. pmid:11842291
McBurney MW et al. Evidence for repeat-induced gene silencing in cultured Mammalian cells: inactivation of tandem repeats of transfected genes. 2002 Exp. Cell Res. pmid:11855851
Hou M et al. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. 2002 Exp. Cell Res. pmid:11855854
Remiszewski SW et al. Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. 2002 J. Med. Chem. pmid:11831887
Kiefer SM et al. Murine Sall1 represses transcription by recruiting a histone deacetylase complex. 2002 J. Biol. Chem. pmid:11836251
Roddie PH et al. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1. 2002 Leukemia pmid:11840267
Taniura S et al. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. 2002 J. Biol. Chem. pmid:11877441
Heltweg B and Jung M A microplate reader-based nonisotopic histone deacetylase activity assay. 2002 Anal. Biochem. pmid:11878795
Kamitani H et al. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. 2002 Neuro-oncology pmid:11916500
Petti MC et al. Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies. 2002 Blood pmid:12130525
Avram D et al. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. 2002 Biochem. J. pmid:12196208
Guo Y et al. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. 2002 J. Biol. Chem. pmid:12198113
Wittich S et al. Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. 2002 J. Med. Chem. pmid:12109913
Toyooka S et al. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. 2002 Clin. Cancer Res. pmid:12114433
Choi HS et al. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. 2002 Biochem. Biophys. Res. Commun. pmid:12200149
Maecker HL et al. Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. 2002 Cancer Cell pmid:12204534
Fang D et al. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. 2002 Nucleic Acids Res. pmid:12136092
Zschocke J et al. Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells. 2002 J. Biol. Chem. pmid:12138116
Yu Z et al. Histone deacetylases augment cytokine induction of the iNOS gene. 2002 J. Am. Soc. Nephrol. pmid:12138131
Li J et al. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. 2002 Mol. Cell. Biol. pmid:12138181
Weston AD et al. Requirement for RAR-mediated gene repression in skeletal progenitor differentiation. 2002 J. Cell Biol. pmid:12105181
Toyooka S et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. 2002 Oncogene pmid:12082623
Maehara K et al. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. 2002 Biochem. Biophys. Res. Commun. pmid:12083788
Iezzi S et al. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12032356
Nielsen J Combinatorial synthesis of natural products. 2002 Curr Opin Chem Biol pmid:12023109
Mikkelsen IM et al. The expression of gamma-glutamyltransferase in rat colon carcinoma cells is distinctly regulated during differentiation and oxidative stress. 2002 Mol. Cell. Biochem. pmid:12030384
Bharadwaj S and Prasad GL Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. 2002 Cancer Lett. pmid:12065096
Ito K et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12070353
Katula KS et al. Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A. 2002 Arch. Biochem. Biophys. pmid:12054478
Wang XQ et al. Histone deacetylase inhibition results in decreased macrophage CD9 expression. 2002 Biochem. Biophys. Res. Commun. pmid:12056820
Rahmani M et al. The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated process. 2002 Exp. Cell Res. pmid:12061815
Westendorf JJ et al. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. 2002 Mol. Cell. Biol. pmid:12391164
McGuinness MC et al. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. 2001 Sep-Oct Mol. Genet. Metab. pmid:11592822
Rombouts K et al. Trichostatin A, lead compound for development of antifibrogenic drugs. 2001 Jul-Sep Acta Gastroenterol. Belg. pmid:11680040
Bovenzi V and Momparler RL Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. 2001 Cancer Chemother. Pharmacol. pmid:11488527
Mishra N et al. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11226290
Chen C et al. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites. 2001 J. Biol. Chem. pmid:11013250